The University of Oxford in the United Kingdom has discovered a gene that controls pain sensitivity by enhancing pain impulses...
Read moreBribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus...
Read moreNovartis’ Kymriah created history five years ago when it became the first gene therapy to be licenced in the United States....
Read moreSeqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in...
Read moreThe Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a...
Read moreIn addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political...
Read moreThe British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as...
Read moreAmarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the...
Read moreTeva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as...
Read moreAs many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years:...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.